GENERAL COMMENTS
This is a Protocol for a network meta-analysis about the effectiveness of 6 Chinese herbs for AECOPD. This will be an interesting study. I have only minor suggestions: -Did you include only reference from peer-reviewed journal? Or also abstract or other material? -Which was the criterion for COPD diagnosis? Did you select only study with COPD confirmed by spirometry? -Could you include also hospital readmission for acute exacerbation of COPD as outcome? -Why do you use only a random effect? According the degree of heterogeneity expressed as I2, you can use a fixed effect if I2 is <50% and a random effect if I2 is > 50%.
-Which statistical test will you use to quantify the presence of publication bias? -Personally I would not include the empty figure of the outline of the search strategy, I would eliminate it.
-I would write a paragraph as "discussion" with the aim and expectation from the results of this meta-analysis.
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GENERAL COMMENTS
The authors studied the best combination medicine from six Chinese herbal formulas in exacerbation of COPD. This study dealt with an important issue in respiratory medicine. COPD exacerbation is common in clinical situation and many physicians are interested in reducing the risk of it. Network meta-analysis is one of the best methods to compare some therapies at once. Although the study is well designed, few issues should be clarified before the publication. 
VERSION 1 -AUTHOR RESPONSE
Reviewer 1: 1.Did you include only reference from peer-reviewed journal? Or also abstract or other material? Response：We also include conference papers, thesis or dissertations. We will screen the abstract, and exclude it if not report enough information. All the screening procedure will present in PRISMA flow chart.
2. Which was the criterion for COPD diagnosis? Did you select only study with COPD confirmed by spirometry? Response：COPD should be confirmed according to the standard diagnostic criteria including the Global Initiative for Chronic Obstructive Lung Disease [GOLD] ; the British Thoracic Society, the American Thoracic Society, the European Respiratory Society or Chinese COPD guideline. All these criterions contain the diagnosis of spirometry. We only include the studies with specified diagnostic criteria. The details of diagnosis were revised in the participants section.
3. Could you include also hospital readmission for acute exacerbation of COPD as outcome? Response: This outcome was included.
4. Why do you use only a random effect? According the degree of heterogeneity expressed as I2, you can use a fixed effect if I2 is <50% and a random effect if I2 is > 50%.
Response: It has mentioned that the choice between a fixed-effect and a random-effects metaanalysis should never be made on the basis of a statistical test for heterogeneity in Cochrane handbook (see section 9.4.3). The random effect model is conservative method that it accounts for both within-study and between-study variability. The relative reference list as below: 1.C Tufanaru, Z Munn, M Stephenson, E Aromataris. Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. International journal of evidence-based healthcare , 2015 , 13 (3) :196
5. Which statistical test will you use to quantify the presence of publication bias? Response: We will conduct egger's regression test to detect the potential publication bias and give
